October 31, 2018
Rose
The pharmaceutical giant signaled that prescription drug price increases could return in 2019 after postponing planned hikes in July. The news was made during Pfizer's third-quarter earnings call, in which the drugmaker also said its profits were up but that revenue did not hit forecasts. Bloomberg also reports on the company's hospital drug problems.
from Kaiser Health News https://ift.tt/2Pz05MV
October 31, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Hospitals, Insurers And Other Health Groups Find Common Ground Criticizing Proposed ‘Public Charge’ Policy- Baby Boomers Are Aging Alone More Than Any Generation In U.S. History, And It’s Creating A Looming Public Health Crisis
- Millions Of Americans Are Eligible For Free Coverage Through Health Law Plans, Study Finds
- On Capitol Hill: Medicare For All; Lowering Health Care Costs; Maternal Mortality Rates; And More
- For Those Who Have Had Dramatic Overdose Videos And Photos Aired To Public, Life Will Never Be The Same
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment